5.4 Neuromuscular Blockade in Critical Illness

Neuromuscular Blockade in Critical Illness

Neuromuscular blocking agents (NMBAs) induce skeletal muscle paralysis. In the ICU, they are primarily used to facilitate mechanical ventilation in patients with severe respiratory failure, manage elevated intracranial pressure, or treat severe muscle spasms (e.g., tetanus). Because of significant potential for harm, their use requires strict protocols and monitoring.

The Golden Rule of NMBAs

NMBAs provide ZERO sedation, amnesia, or analgesia.

Administering a paralytic to an awake or inadequately sedated patient causes terrifying psychological trauma and distress. Therefore, before initiating an NMBA, the patient must be deeply sedated (RASS -4 to -5) and adequately treated for pain. Sedation and analgesia must be continued without interruption throughout the duration of paralysis.

Indications in the ICU

Acute Respiratory Distress Syndrome (ARDS)

Historically, continuous NMBA infusions were routinely used in early, severe ARDS based on earlier trials. However, the subsequent ROSE trial demonstrated that routine early NMBA use did not improve mortality compared to a strategy of deep sedation alone, but did increase adverse events.

Currently, guidelines recommend against the routine use of continuous NMBAs in ARDS. Instead, they should be reserved for patients with severe ARDS (PaO2/FiO2 < 150) who exhibit persistent ventilator dyssynchrony (e.g., "fighting the ventilator," double-triggering) despite optimized sedation, analgesia, and ventilator settings.

Other indications include:

• Shivering control during targeted temperature management (therapeutic hypothermia).
• Status asthmaticus refractory to standard therapy.
• Open abdomen to facilitate closure (in specific surgical contexts).

Pharmacology of NMBAs

NMBAs are divided into depolarizing and non-depolarizing agents.

• Succinylcholine is a depolarizing agent with a very rapid onset and short duration (5-10 mins). It is used exclusively for rapid sequence intubation (RSI). It is contraindicated in hyperkalemia, major burns, crush injuries, and significant neuromuscular disease due to the risk of life-threatening hyperkalemia.
• Non-depolarizing agents are used for continuous infusions in the ICU. They act as competitive antagonists at the nicotinic acetylcholine receptor.

Monitoring: Train-of-Four (TOF)

When a continuous NMBA infusion is utilized, the dose must be titrated to the minimum effective level to achieve the clinical goal (e.g., ventilator synchrony) while minimizing toxicity. This is achieved using peripheral nerve stimulation, most commonly the Train-of-Four (TOF).

How TOF Works:

1. Two electrodes are placed over a peripheral nerve, typically the ulnar nerve (causing thumb adduction) or the facial nerve (causing eyebrow twitch).
2. The device delivers four consecutive electrical stimuli.
3. The clinician observes or palpates the number of muscle twitches.

Interpretation:

• 4/4 twitches: 0-75% receptor blockade (insufficient paralysis).
• 1 to 2/4 twitches: 85-90% receptor blockade (optimal therapeutic range for most ICU indications).
• 0/4 twitches: 100% receptor blockade (overshoot; the dose should be reduced as the patient is over-paralyzed).

Crucial Point: TOF should always be used in conjunction with clinical assessment. If a patient has 3 twitches but is perfectly synchronous with the ventilator and meeting oxygenation goals, the NMBA dose does not necessarily need to be increased.

Complications of NMBAs

1. ICU-Acquired Weakness (ICUAW): Prolonged use of NMBAs increases the risk of severe, long-lasting muscle weakness. This risk is synergistically increased when NMBAs are administered concurrently with systemic corticosteroids.
2. Masking of Seizures: NMBAs paralyze motor function but do not stop brain activity. An EEG is required if status epilepticus is suspected.
3. Corneal Abrasions: Paralyzed patients cannot blink. Eye care with lubricating drops and taping the eyes shut is essential.
4. Venous Thromboembolism (VTE) and Pressure Ulcers: Due to complete immobility, rigorous DVT prophylaxis and frequent repositioning are required.

Clinical Scenario

A 60-year-old male with severe ARDS is intubated. Despite receiving continuous infusions of fentanyl and propofol, achieving a RASS of -4, he continues to double-trigger the ventilator, causing dangerous spikes in his airway pressures. The critical care physician decides to initiate a continuous infusion of cisatracurium.

Discussion: The initiation of an NMBA is appropriate here because the patient has refractory ventilator dyssynchrony despite deep sedation. Cisatracurium is a logical choice, especially if the patient has underlying organ dysfunction. The pharmacist must ensure that the propofol and fentanyl infusions are maintained throughout the paralysis. The nurse will initiate TOF monitoring, titrating the cisatracurium to a goal of 1-2 twitches while ensuring the patient's airway pressures stabilize.